Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Stephen Hoge

Moderna, Merck's Cancer Vaccine Breakthrough Raises Hope For New Wave Of Personalized Treatments

Moderna and Merck's experimental cancer vaccine has delivered positive results in a late-stage melanoma trial, giving a major boost to personalized mRNA treatments as rivals including BioNTech and Roche pursue similar approaches.

International Business Times

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target specific tumor mutations. The vaccine, combined with Keytruda, significantly reduced cancer recurrence in trials. Doctors are hopeful this approach will expand to treat many other cancer types. Further trials are…

The Economic Times

Moderna paid the US more than enough for COVID shot partnership, executive says

WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna eyes testing of mpox, bird flu vaccines in humans this year: 'They're really for public health'

A shot against mpox would be valuable in case outbreaks reemerge, and the company sees bird flu as a “clear threat,” the company's president said.

Fortune

The Future of Boosters Is Somewhere Between Unnecessary and Urgent

Until there’s a universal coronavirus vaccine, the future of additional shots is a murky work in progress—but more rounds seem increasingly likely.

Organisations

Centers for Disease Control and Prevention

National Institute of Allergy and Infectious Diseases

22 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.